BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 28187375)

  • 1. A comparative study of nuclear 8-hydroxyguanosine expression in Autoimmune Thyroid Diseases and Papillary Thyroid Carcinoma and its relationship with p53, Bcl-2 and Ki-67 cancer related proteins.
    Mseddi M; Ben Mansour R; Gouiia N; Mnif F; Bousselaa R; Abid M; Boudaouara T; Attia H; Lassoued S
    Adv Med Sci; 2017 Mar; 62(1):45-51. PubMed ID: 28187375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study of the oxidative profile in Graves' disease, Hashimoto's thyroiditis, and papillary thyroid cancer.
    Lassoued S; Mseddi M; Mnif F; Abid M; Guermazi F; Masmoudi H; El Feki A; Attia H
    Biol Trace Elem Res; 2010 Dec; 138(1-3):107-15. PubMed ID: 20204550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression profile of biomarkers altered in papillary and anaplastic thyroid carcinoma: Contribution of Tunisian patients.
    Fourati A; El Amine O; Ben Ayoub W; Cherni I; Goucha A; El May MV; Gamoudi A; El May A
    Bull Cancer; 2017 May; 104(5):433-441. PubMed ID: 28185633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical and pathological differences between papillary thyroid carcinoma with Graves' disease and papillary thyroid carcinoma with Hashimoto's thyroiditis].
    Xu DD; Lun Y; Liu X; Jiang H; Song JB; Duan ZQ; Xin SJ; Zhang J
    Zhonghua Yi Xue Za Zhi; 2017 Aug; 97(32):2491-2495. PubMed ID: 28835054
    [No Abstract]   [Full Text] [Related]  

  • 5. Osteopontin levels in patients with papillary thyroid cancer according to the presence of Hashimoto's thyroiditis.
    Park SH; Park CS; Kim YI; Nam-Goong IS; Kim YS; Lee JC; Choi JI; Park JW; Kim ES
    Asian Pac J Cancer Prev; 2015; 16(6):2447-51. PubMed ID: 25824779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Differential protein expressions in papillary thyroid carcinoma patients with or without Hashimoto's thyroiditis].
    Lu HZ; Zhang N; Liu W; Zhu XY; Qi D; Wang Y; Liu XY; Li ZJ
    Zhonghua Zhong Liu Za Zhi; 2020 Jun; 42(6):463-468. PubMed ID: 32575941
    [No Abstract]   [Full Text] [Related]  

  • 7. Prognostic value of oncoprotein expressions in thyroid papillary carcinoma.
    Balta AZ; Filiz AI; Kurt Y; Sucullu I; Yucel E; Akin ML
    Med Oncol; 2012 Jun; 29(2):734-41. PubMed ID: 21547408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of proliferating cell nuclear antigen, thyroid transcription factor-1, Ki-67, p63, p53 and high-molecular weight cytokeratin expressions in papillary thyroid carcinoma, follicular carcinoma, and follicular adenoma.
    Tan A; Etit D; Bayol U; Altinel D; Tan S
    Ann Diagn Pathol; 2011 Apr; 15(2):108-16. PubMed ID: 21315633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-4, IL-10 and high sensitivity-CRP as potential serum biomarkers of persistent/recurrent disease in papillary thyroid carcinoma with/without Hashimoto's thyroiditis.
    Stanciu AE; Serdarevic N; Hurduc AE; Stanciu MM
    Scand J Clin Lab Invest; 2015 Nov; 75(7):539-48. PubMed ID: 26305420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of papillary thyroid carcinoma patients with Hashimoto thyroiditis: evaluation of oxidative stress and inflammatory markers.
    Lopes NMD; Lens HHM; da Silva Brito WA; Bianchi JK; Marinello PC; Cecchini R; Armani A; Cecchini AL
    Clin Transl Oncol; 2022 Dec; 24(12):2366-2378. PubMed ID: 35902455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical analysis of Hashimoto thyroiditis coexistent with papillary thyroid cancer in 1392 patients.
    Liang J; Zeng W; Fang F; Yu T; Zhao Y; Fan X; Guo N; Gao X
    Acta Otorhinolaryngol Ital; 2017 Oct; 37(5):393-400. PubMed ID: 29165434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidentally Discovered Papillary Thyroid Microcarcinomas Are More Frequently Found in Patients with Chronic Lymphocytic Thyroiditis Than with Multinodular Goiter or Graves' Disease.
    Paparodis RD; Karvounis E; Bantouna D; Chourpiliadis C; Chourpiliadi H; Livadas S; Imam S; Jaume JC
    Thyroid; 2020 Apr; 30(4):531-535. PubMed ID: 31950881
    [No Abstract]   [Full Text] [Related]  

  • 13. Histological and immunohistochemical aspects of papillary thyroid cancer.
    Radu TG; Mogoantă L; Busuioc CJ; Stănescu C; Grosu F
    Rom J Morphol Embryol; 2015; 56(2 Suppl):789-95. PubMed ID: 26429174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hashimoto's thyroiditis as a risk factor of papillary thyroid cancer may improve cancer prognosis.
    Lun Y; Wu X; Xia Q; Han Y; Zhang X; Liu Z; Wang F; Duan Z; Xin S; Zhang J
    Otolaryngol Head Neck Surg; 2013 Mar; 148(3):396-402. PubMed ID: 23300224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of papillary thyroid carcinoma-associated molecular markers and their significance in follicular epithelial dysplasia with papillary thyroid carcinoma-like nuclear alterations in Hashimoto's thyroiditis.
    Ma H; Yan J; Zhang C; Qin S; Qin L; Liu L; Wang X; Li N
    Int J Clin Exp Pathol; 2014; 7(11):7999-8007. PubMed ID: 25550843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological characterization and prognostic implication of FOXP3 and CK19 expression in papillary thyroid carcinoma and concomitant Hashimoto's thyroiditis.
    Mohamed SY; Ibrahim TR; Elbasateeny SS; Abdelaziz LA; Farouk S; Yassin MA; Embaby A
    Sci Rep; 2020 Jun; 10(1):10651. PubMed ID: 32606302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RASSF10 is Epigenetically Inactivated and Suppresses Cell Proliferation and Induces Cell Apoptosis by Activating the p53 Signalling Pathway in Papillary Thyroid Carcinoma Cancer.
    Fan C; Wang W; Jin J; Yu Z; Xin X
    Cell Physiol Biochem; 2017; 41(3):1229-1239. PubMed ID: 28268222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Mcl-1 and Ki-67 in Papillary Thyroid Carcinomas.
    Maia FF; Vassallo J; Pinto GA; Pavin EJ; Matos PS; Zantut-Wittmann DE
    Exp Clin Endocrinol Diabetes; 2016 Apr; 124(4):209-14. PubMed ID: 27123780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Papillary Thyroid Carcinoma Emerging from Hashimoto Thyroiditis Demonstrates Increased PD-L1 Expression, Which Persists with Metastasis.
    Lubin D; Baraban E; Lisby A; Jalali-Farahani S; Zhang P; Livolsi V
    Endocr Pathol; 2018 Dec; 29(4):317-323. PubMed ID: 30121940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic evidence of reactive oxygen species elevation in papillary thyroid carcinoma with Hashimoto thyroiditis.
    Yi JW; Park JY; Sung JY; Kwak SH; Yu J; Chang JH; Kim JH; Ha SY; Paik EK; Lee WS; Kim SJ; Lee KE; Kim JH
    Endocr J; 2015; 62(10):857-77. PubMed ID: 26211532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.